SFDYX
Price
$32.48
Change
+$0.35 (+1.09%)
Updated
Sep 26 closing price
Net Assets
72.94M
VIMSX
Price
$79.84
Change
+$0.88 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

SFDYX vs VIMSX

Header iconSFDYX vs VIMSX Comparison
Open Charts SFDYX vs VIMSXBanner chart's image
SEI Mid-Cap Y (SIMT)
Price$32.48
Change+$0.35 (+1.09%)
VolumeN/A
Net Assets72.94M
Vanguard Mid Cap Index Investor
Price$79.84
Change+$0.88 (+1.11%)
VolumeN/A
Net Assets199.16B
SFDYX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SFDYX vs. VIMSX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SFDYX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. SFDYX (72.9M). VIMSX pays higher dividends than SFDYX: VIMSX (1.35) vs SFDYX (0.88). SFDYX was incepted earlier than VIMSX: SFDYX (10 years) vs VIMSX (27 years). SFDYX (0.74) is less costly to investors than VIMSX (0.17). SFDYX is a more actively managed with annual turnover of: 61.00 vs. VIMSX (16.00). VIMSX has a lower initial minimum investment than SFDYX: VIMSX (3000) vs SFDYX (100000). VIMSX annual gain was more profitable for investors over the last year : 11.57 vs. SFDYX (1.85). VIMSX return over 5 years is better than : 70.75 vs. SFDYX (47.11).
SFDYXVIMSXSFDYX / VIMSX
Total Expense Ratio0.740.17435%
Annual Report Gross Expense Ratio0.740.17435%
Fund Existence10 years27 years-
Gain YTD8.74210.84581%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets72.9M199B0%
Annual Yield % from dividends0.881.3565%
Returns for 1 year1.8511.5716%
Returns for 3 years46.5255.7483%
Returns for 5 years47.1170.7567%
Returns for 10 yearsN/A160.66-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
APGE38.220.70
+1.87%
Apogee Therapeutics
ASTS49.09-0.30
-0.61%
AST SpaceMobile
JDZG1.81-0.02
-1.09%
Jiade Limited
LIDR2.36-0.03
-1.26%
AEye